DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

- The collaboration will use AI to identify potential biological targets and therapies that could be repurposed for dengue to prevent disease progression - Dengue is a climate-sensitive

Related Keywords

New York ,United States ,London ,City Of ,United Kingdom ,Prnewswire Benevolent ,Eli Lilly ,Anne Phelan ,Charles Mowbray ,World Health Organization ,Neglected Disease ,Benevolent Platform ,Discovery Director ,Chief Scientific Officer ,Dndi ,Benevolentai ,Ollaborate ,Ccelerate ,Life ,Caving ,Drug ,Discovery ,Research ,Dengue ,